JPH06122606A - Antibacterial material selective to gram-negative bacteria and selective sterilization - Google Patents
Antibacterial material selective to gram-negative bacteria and selective sterilizationInfo
- Publication number
- JPH06122606A JPH06122606A JP20325693A JP20325693A JPH06122606A JP H06122606 A JPH06122606 A JP H06122606A JP 20325693 A JP20325693 A JP 20325693A JP 20325693 A JP20325693 A JP 20325693A JP H06122606 A JPH06122606 A JP H06122606A
- Authority
- JP
- Japan
- Prior art keywords
- gram
- antibacterial material
- negative bacteria
- silver complex
- silica gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 48
- 239000000463 material Substances 0.000 title claims abstract description 43
- 241000894006 Bacteria Species 0.000 title claims abstract description 33
- 230000001954 sterilising effect Effects 0.000 title claims abstract description 10
- 238000004659 sterilization and disinfection Methods 0.000 title claims abstract description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 39
- 229910052709 silver Inorganic materials 0.000 claims abstract description 38
- 239000004332 silver Substances 0.000 claims abstract description 38
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 37
- 239000000741 silica gel Substances 0.000 claims abstract description 31
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 13
- 229910021607 Silver chloride Inorganic materials 0.000 claims abstract description 10
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims abstract description 10
- 150000003839 salts Chemical class 0.000 claims description 28
- 239000000203 mixture Substances 0.000 abstract description 9
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 abstract description 8
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 235000010265 sodium sulphite Nutrition 0.000 abstract description 4
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 abstract description 4
- 235000019345 sodium thiosulphate Nutrition 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 16
- 239000002245 particle Substances 0.000 description 11
- 239000012266 salt solution Substances 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 229920003002 synthetic resin Polymers 0.000 description 8
- 239000000057 synthetic resin Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 238000003756 stirring Methods 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000000576 coating method Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 4
- 229940071536 silver acetate Drugs 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000588769 Proteus <enterobacteria> Species 0.000 description 3
- 241000607142 Salmonella Species 0.000 description 3
- 241000607720 Serratia Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 235000010724 Wisteria floribunda Nutrition 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000233866 Fungi Species 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- 239000011247 coating layer Substances 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000108056 Monas Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 1
- MFIHOCAEOJNSOL-UHFFFAOYSA-N [Ag]C#N Chemical compound [Ag]C#N MFIHOCAEOJNSOL-UHFFFAOYSA-N 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229940045505 klebsiella pneumoniae Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910001120 nichrome Inorganic materials 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 150000003378 silver Chemical class 0.000 description 1
- WYCFMBAHFPUBDS-UHFFFAOYSA-L silver sulfite Chemical compound [Ag+].[Ag+].[O-]S([O-])=O WYCFMBAHFPUBDS-UHFFFAOYSA-L 0.000 description 1
- JLNAAYCOBVWTMC-UHFFFAOYSA-M silver;hydrogen sulfite Chemical compound [Ag+].OS([O-])=O JLNAAYCOBVWTMC-UHFFFAOYSA-M 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 239000012808 vapor phase Substances 0.000 description 1
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、シリカゲルに銀錯塩を
担持させた抗菌材に関し、詳しくはグラム陰性菌に選択
性を有する抗菌材に関する。また、該抗菌材による除菌
方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an antibacterial material in which silver complex salt is supported on silica gel, and more particularly to an antibacterial material having selectivity for Gram-negative bacteria. Further, the present invention relates to a sterilization method using the antimicrobial material.
【0002】[0002]
【従来の技術】従来より、抗菌抗黴性材料をシリカゲル
等の多孔質粒体に担持させた抗菌材が知られている。こ
のような抗菌材の一種として、銀錯塩をシリカゲルに担
持させた抗菌材がある。2. Description of the Related Art Conventionally, an antibacterial material in which an antibacterial and antifungal material is supported on porous particles such as silica gel has been known. As one of such antibacterial materials, there is an antibacterial material in which a silver complex salt is supported on silica gel.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、銀錯塩
を使用した抗菌材で特定の菌に選択的に有効なものは、
いまだ知られていなかった。一方、産業界において、特
に他の有用な菌とグラム陰性菌とが混在するコロニーか
らグラム陰性菌を徐菌して他の有用な菌を繁殖させるこ
と等のように、グラム陰性菌のみを徐菌することが切望
されていた。However, an antibacterial material using a silver complex salt, which is selectively effective against a specific bacterium, is
It was not known yet. On the other hand, in the industrial world, particularly, only Gram-negative bacteria are cultivated, such as grading Gram-negative bacteria from a colony containing other useful bacteria and Gram-negative bacteria to propagate other useful bacteria. There was a long-awaited desire to become fungi.
【0004】以上の課題を解消するため、本発明はグラ
ム陰性菌に選択性を有する抗菌材およびグラム陰性菌を
選択的に除菌する除菌方法を提供することを目的とす
る。In order to solve the above problems, an object of the present invention is to provide an antibacterial material having selectivity for Gram-negative bacteria and a sterilization method for selectively erasing Gram-negative bacteria.
【0005】[0005]
【課題を解決するための手段及び作用】上記の課題を解
決するため、本発明の第1発明のグラム陰性菌に選択性
を有する抗菌材は、塩化銀から調製した銀錯塩をシリカ
ゲルに担持させたことを要旨とする。In order to solve the above-mentioned problems, an antibacterial material having selectivity for Gram-negative bacteria of the first invention of the present invention comprises a silver complex salt prepared from silver chloride supported on silica gel. The main point is that.
【0006】また、第2発明の選択的除菌方法は、第1
発明の抗菌材を使用し、グラム陰性菌を選択的に除菌す
ることを要旨とする。以下、本発明の第1発明につき更
に詳しく説明する。本発明に使用可能な銀錯塩は、出発
原料に塩化銀を使用して調製する以外特に限定するもの
ではないが、シアノ銀錯塩、アンミン銀錯塩、亜硫酸銀
錯塩、亜硫酸水素銀錯塩、チオスルファト銀錯塩、又は
これらの混合物などが好ましく、特にチオスルファト銀
錯塩が好ましい。The selective sterilization method of the second invention is the first
The gist of the present invention is to selectively remove Gram-negative bacteria by using the antibacterial material of the invention. Hereinafter, the first invention of the present invention will be described in more detail. The silver complex salt usable in the present invention is not particularly limited except that it is prepared by using silver chloride as a starting material, but is not limited to cyano silver complex salt, ammine silver complex salt, silver sulfite complex salt, silver hydrogen sulfite complex salt, and thiosulfato silver complex salt. , Or a mixture thereof and the like, and particularly thiosulfato silver complex salt is preferable.
【0007】出発原料として塩化銀以外のものを使用し
た銀錯塩をシリカゲルに担持した場合、抗菌活性は示す
もののグラム陰性菌に対する選択性はみられない。ま
た、出発原料として硝酸銀、酢酸銀を使用した銀錯塩を
シリカゲルに担持した抗菌材の場合、水道水のようにハ
ロゲン(フッ素を除く)を含む水と抗菌材とが接触する
と白濁が生じたり、特に硝酸銀を用いた場合、光によっ
て褐変したりすることが問題となったが、塩化銀を用い
た場合、これらの欠点は見られない。When silica gel is loaded with a silver complex salt other than silver chloride as a starting material, it exhibits antibacterial activity but shows no selectivity for Gram-negative bacteria. Further, in the case of an antibacterial material in which a silver complex salt using silver nitrate or silver acetate as a starting material is supported on silica gel, when water containing a halogen (excluding fluorine) such as tap water comes into contact with the antibacterial material, cloudiness may occur, In particular, when silver nitrate was used, browning due to light was a problem, but when silver chloride was used, these defects were not observed.
【0008】本発明で使用するシリカゲルは、特に限定
するものではなく、その製造方法としては例えば気相
法、湿式法など公知の方法で製造可能である。また、シ
リカゲルの粒径も特に限定するものではなく、使用目的
に応じて、適宜の粒径のものを選択して使用できる。例
えば、合成樹脂製品の表面への抗菌性の付与を目的とし
て本発明の抗菌材を合成樹脂に混合する場合、その平均
粒子径は約0.1〜100μmの範囲が好ましい。この
粒径範囲であると、合成樹脂との混合効率が特に良好と
なり、合成樹脂表面に均等に抗菌効果を付与できる。抗
菌材の粒径をこれ以下にしても合成樹脂表面にて得られ
る抗菌効果には大きな差はなく、樹脂中で、抗菌材が凝
集しやすく、分散不良になりやすい。また、抗菌材の粒
径が大きくなると、例えば混合した合成樹脂の引張強度
が部分的に低下するなどの不利な点がある。したがっ
て、合成樹脂に混合する場合の抗菌材の粒径は上記の範
囲が好ましい。The silica gel used in the present invention is not particularly limited and can be manufactured by a known method such as a vapor phase method or a wet method. Also, the particle size of silica gel is not particularly limited, and an appropriate particle size can be selected and used according to the purpose of use. For example, when the antibacterial material of the present invention is mixed with a synthetic resin for the purpose of imparting antibacterial properties to the surface of the synthetic resin product, the average particle size thereof is preferably in the range of about 0.1 to 100 μm. Within this particle size range, the mixing efficiency with the synthetic resin becomes particularly good, and the antibacterial effect can be imparted evenly to the surface of the synthetic resin. Even if the particle size of the antibacterial material is smaller than this, there is no great difference in the antibacterial effect obtained on the surface of the synthetic resin, and the antibacterial material is likely to aggregate in the resin, resulting in poor dispersion. Further, when the particle size of the antibacterial material is large, there are disadvantages such that the tensile strength of the mixed synthetic resin is partially reduced. Therefore, the particle size of the antibacterial material when mixed with the synthetic resin is preferably within the above range.
【0009】シリカゲルの細孔容積、平均細孔径も、用
途に応じて適宜の範囲を選択し得る。銀錯塩をシリカゲ
ルに担持させる方法は、特に限定はしないが、上記の銀
錯塩を溶質とする溶液中にシリカゲルを加えて攪拌し、
銀錯塩をシリカゲルに吸着させた後、濾過あるいは蒸散
などにてシリカゲルを溶液から分離する方法が簡便であ
る。The pore volume and the average pore diameter of silica gel can be selected in an appropriate range depending on the application. The method for supporting the silver complex salt on silica gel is not particularly limited, but silica gel is added to the solution containing the silver complex salt as a solute and stirred,
A method of adsorbing the silver complex salt on silica gel and then separating the silica gel from the solution by filtration or evaporation is convenient.
【0010】更に、銀錯塩を担持したシリカゲルに徐放
性を付与するために、シリカコーティング層を設けても
よい。このコーティング方法は特に限定されないが、例
えば、テトラアルコキシシランのように脱離基を有する
ケイ素化合物の溶液中に、銀錯塩を担持したシリカゲル
を投入し、混合攪拌後乾燥する方法などが挙げられる。Further, a silica coating layer may be provided in order to impart a sustained release property to the silica gel carrying the silver complex salt. The coating method is not particularly limited, and examples thereof include a method in which silica gel carrying a silver complex salt is added to a solution of a silicon compound having a leaving group such as tetraalkoxysilane, and the mixture is stirred and dried, and the like.
【0011】本発明の抗菌材は、大部分の銀錯塩がシリ
カゲルの細孔に吸着されて担持されているため、この銀
錯塩が細孔から徐々に放出されて周囲に抗菌効果を及ぼ
す。シリカコーティング層を表面に設けた場合、銀錯塩
の放出を一層制限することが可能で、長期にわたって抗
菌材の効能を維持することができる。In the antibacterial material of the present invention, most of the silver complex salt is adsorbed and carried by the pores of silica gel, and this silver complex salt is gradually released from the pores to exert an antibacterial effect on the surroundings. When the silica coating layer is provided on the surface, the release of the silver complex salt can be further restricted, and the effect of the antibacterial material can be maintained for a long period of time.
【0012】続いて、第2発明の選択的除菌方法につい
て詳細を説明する。第1発明の抗菌材を使用してグラム
陰性菌を選択的に除菌するには、該抗菌材を対象物、対
象箇所に直接散布する他、合成樹脂に混合してその成形
品表面を除菌する、塗料に混合して対象物、対象箇所に
塗布する、カラムなどに充填しておき除菌対称となる水
などの液体を抗菌材に接触通過させるなどの手段を採用
できる。これらの他にも除菌対象等に応じて適宜の手段
を用いることが可能である。Next, the selective sterilization method of the second invention will be described in detail. In order to selectively remove Gram-negative bacteria by using the antibacterial material of the first invention, the antibacterial material is sprayed directly on the object or the target area, or the surface of the molded product is removed by mixing with the synthetic resin. It is possible to employ means such as sterilizing, mixing with a coating material and applying it to a target object or a target portion, or filling a column or the like with a liquid such as water that is in a sterilizing symmetry to pass through the antibacterial material. In addition to these, it is possible to use an appropriate means depending on the sterilization target and the like.
【0013】本発明の抗菌材はグラム陰性菌を選択的に
除菌するので、例えば有用菌とグラム陰性菌とが混在す
るコロニーから、グラム陰性菌のみを除菌することがで
きる。Since the antibacterial material of the present invention selectively eliminates Gram-negative bacteria, it is possible to eliminate only Gram-negative bacteria from colonies in which useful bacteria and Gram-negative bacteria are mixed.
【0014】[0014]
【実施例】以下に、本発明の好適な実施例をあげて、本
発明を詳細に説明する。ただし、本発明は以下の実施例
になんら限定されることなく、種々の態様で実施できる
ことはいうまでもない。 [実施例1]チオ硫酸ナトリウム32gを40℃のイオ
ン交換水300mlに加えて混合攪拌し溶解させた後、
塩化銀4gを加えて攪拌し、塩化銀を完全に溶解させ
た。この溶液に亜硫酸ナトリウム0.8g、亜硫酸水素
ナトリウム0.8gを攪拌しながら加え、溶液が透明に
なるまで攪拌を継続し、チオスルファト銀錯塩溶液を得
た。EXAMPLES The present invention will be described in detail below with reference to preferred examples of the present invention. However, it goes without saying that the present invention is not limited to the following examples and can be implemented in various modes. [Example 1] 32 g of sodium thiosulfate was added to 300 ml of ion-exchanged water at 40 ° C, and mixed and stirred to dissolve,
4 g of silver chloride was added and stirred to completely dissolve silver chloride. Sodium sulfite (0.8 g) and sodium hydrogen sulfite (0.8 g) were added to this solution with stirring, and the stirring was continued until the solution became transparent to obtain a thiosulfato silver complex salt solution.
【0015】このチオスルファト銀錯塩溶液に平均粒子
径2.6μmのシリカゲル(商品名サイリシア#55
0、富士シリシア化学(株)製)100gを加えて約5分
間攪拌し、シリカゲルに銀錯塩を担持させた。続いて、
チオスルファト銀錯塩溶液とシリカゲルとの混合物をロ
ータリーエバポレータ(商品名ロータリーエバポレータ
ーRE47、ヤマト科学(株)製)にて、温度約60℃、
圧力を約3000Pa以下に保って溶媒成分を蒸発させ
て除去することにより、本発明の抗菌材を得た。 [実施例2]チオ硫酸ナトリウム64gを40℃のイオ
ン交換水300mlに加えて混合攪拌し、溶解させた
後、塩化銀8gを加えて攪拌し、塩化銀を完全に溶解さ
せた。この溶液に亜硫酸ナトリウム1.6g、亜硫酸水
素ナトリウム1.6gを攪拌しながら加え、溶液が透明
になるまで攪拌を継続し、チオスルファト銀錯塩溶液を
得た。This thiosulfato silver complex salt solution was added to silica gel having an average particle diameter of 2.6 μm (trade name: Sylysia # 55).
0, 100 g of Fuji Silysia Chemical Ltd. was added and stirred for about 5 minutes to support the silver complex salt on silica gel. continue,
The mixture of the thiosulfato silver complex salt solution and silica gel was heated by a rotary evaporator (trade name: rotary evaporator RE47, manufactured by Yamato Scientific Co., Ltd.) at a temperature of about 60 ° C.
The antibacterial material of the present invention was obtained by evaporating and removing the solvent component while maintaining the pressure at about 3000 Pa or less. Example 2 64 g of sodium thiosulfate was added to 300 ml of ion-exchanged water at 40 ° C., mixed and stirred to dissolve, and then 8 g of silver chloride was added and stirred to completely dissolve silver chloride. Sodium sulfite (1.6 g) and sodium hydrogen sulfite (1.6 g) were added to this solution with stirring, and the stirring was continued until the solution became transparent to obtain a thiosulfato silver complex salt solution.
【0016】このチオスルファト銀錯塩溶液に平均粒径
分布2.6μmのシリカゲル(商品名サイリシア#55
0、富士シリシア化学(株)製)100gを加えて約5分
間攪拌し、シリカゲルに銀錯塩を担持させた。続いて、
チオスルファト銀錯塩溶液とシリカゲルとの混合物をロ
ータリーエバポレータ(商品名ロータリーエバポレータ
ーRE47、ヤマト科学(株)製)にて、温度約60℃、
圧力を約3000Pa以下に保って溶媒成分を蒸発させ
て除去することにより、本発明の抗菌材を得た。 [実施例3]実施例1の抗菌材50gを、テトラエトキ
シシラン50gとメタノール90gとイオン交換水10
gとともに混合し、ロータリーエバポレーターにて、温
度50℃、圧力を約3000Pa以下に保って溶媒成分
の除去を行うと同時にシリカコーティングを施す。固化
したものを、更にロータリーエバポレーターにて、前記
条件下で12時間真空乾燥させることにより、本発明の
抗菌材を得た。 [実施例4]実施例2の抗菌材50gを使用したこと以
外は、実施例3と同様にしてシリカコーティングを施
し、本発明の抗菌材を得た。 [比較例1]40℃のイオン交換水300mlに酢酸銀
2.32gを加えてホモジナイザで約5分間攪拌し、酢
酸銀溶液を得た。この酢酸銀溶液に亜硫酸ナトリウム1
0.0gを攪拌しながら加え、溶液が透明になるまで攪
拌を継続した。その後、この溶液にチオ硫酸ナトリウム
6.6gを加えて約5分間攪拌し、チオスルファト銀錯
塩溶液を得た。In this thiosulfato silver complex salt solution, silica gel having a mean particle size distribution of 2.6 μm (trade name Sylysia # 55
0, 100 g of Fuji Silysia Chemical Ltd. was added and stirred for about 5 minutes to support the silver complex salt on silica gel. continue,
The mixture of the thiosulfato silver complex salt solution and silica gel was heated by a rotary evaporator (trade name: rotary evaporator RE47, manufactured by Yamato Scientific Co., Ltd.) at a temperature of about 60 ° C.
The antibacterial material of the present invention was obtained by evaporating and removing the solvent component while maintaining the pressure at about 3000 Pa or less. [Example 3] 50 g of the antibacterial material of Example 1, 50 g of tetraethoxysilane, 90 g of methanol and 10 parts of ion-exchanged water.
The mixture is mixed with g and the solvent component is removed by a rotary evaporator while keeping the temperature at 50 ° C. and the pressure at about 3000 Pa or less, and simultaneously silica coating is applied. The solidified product was further dried in a rotary evaporator under vacuum for 12 hours to obtain an antibacterial material of the present invention. [Example 4] A silica coating was applied in the same manner as in Example 3 except that 50 g of the antibacterial material of Example 2 was used to obtain an antibacterial material of the present invention. [Comparative Example 1] 2.32 g of silver acetate was added to 300 ml of ion-exchanged water at 40 ° C., and the mixture was stirred with a homogenizer for about 5 minutes to obtain a silver acetate solution. Sodium sulfite 1 in this silver acetate solution
0.0 g was added with stirring and stirring was continued until the solution became clear. Then, 6.6 g of sodium thiosulfate was added to this solution and stirred for about 5 minutes to obtain a thiosulfato silver complex salt solution.
【0017】このチオスルファト銀錯塩溶液に平均粒子
径2.6μmのシリカゲル(商品名サイリシア#55
0、富士シリシア化学(株)製)50.0gを加えて約
10分間攪拌し、シリカゲルに銀錯塩を担持させた。続
いて、チオスルファト銀錯塩溶液とシリカゲルとの混合
物をロータリーエバポレータ(商品名ロータリーエバポ
レータRE47、ヤマト科学(株)製)にて、温度約5
0℃、圧力を約3000Pa以下に保って溶媒成分を蒸
発させて除去し、銀錯塩を担持したシリカゲルを得た。 [MIC(最小発育阻止濃度)の測定]上記実施例1〜
5で得た抗菌材及び比較例1を試料として、以下の方法
で最小発育阻止濃度を測定した。This thiosulfato silver complex salt solution was added to silica gel having an average particle diameter of 2.6 μm (trade name: Sylysia # 55).
0, 50.0 g of Fuji Silysia Chemical Ltd. was added and stirred for about 10 minutes to support a silver complex salt on silica gel. Subsequently, the mixture of the thiosulfato silver complex salt solution and silica gel was heated at a temperature of about 5 with a rotary evaporator (trade name: rotary evaporator RE47, manufactured by Yamato Scientific Co., Ltd.).
The solvent component was removed by evaporation by keeping the pressure at 0 ° C. and the pressure at about 3000 Pa or less to obtain a silica gel carrying a silver complex salt. [Measurement of MIC (Minimum Inhibitory Concentration)] Examples 1 to 1 above
Using the antibacterial material obtained in No. 5 and Comparative Example 1 as samples, the minimum inhibitory concentration was measured by the following method.
【0018】即ち、任意濃度にて試料を添加した複数の
寒天平板培地に接種用菌液を接種し培養する。菌が発育
を阻止された際の、試料の最低濃度を最小発育阻止濃度
とした。結果を表1に示す。寒天平板培地の調整、接種
用菌液の調整及び培養は、以下のようになされた。 ・寒天平板培地の調製 滅菌精製水で、次の濃度の試料懸濁液を調整した。試料
濃度は、40,000ppm、20,000ppm、1
0,000ppm、5,000ppm、2,500pp
m、1,250ppm、625ppm、313ppm、
156ppm、78ppmである。That is, a plurality of agar plate media to which a sample is added at an arbitrary concentration is inoculated with the inoculum bacterial solution and cultured. The minimum concentration of the sample when the growth of the bacteria was inhibited was defined as the minimum inhibitory concentration. The results are shown in Table 1. The preparation of the agar plate medium, the preparation of the inoculum bacterial solution and the culture were performed as follows. -Preparation of agar plate medium A sample suspension having the following concentration was prepared with sterile purified water. Sample concentration is 40,000ppm, 20,000ppm, 1
50,000ppm, 5,000ppm, 2,500pp
m, 1,250 ppm, 625 ppm, 313 ppm,
It is 156 ppm and 78 ppm.
【0019】次に、溶解後50〜60℃となった感受性
測定用培地(Mueller−Hinton寒天培地
(DIFCO社製))に、上記の各懸濁液を培地の1/
9量加えて、充分に混合した後、シャーレに分けて固化
させ、寒天平板培地とした。また、実施例で使用したの
と同じシリカゲルを試料として、上記と同様に寒天平板
培地を調製し、これを比較例とした。 ・接種用菌液の調製 増菌用培地[ミューラー ヒントン ブロス(Muel
ler−HintonBroth)(DIFCO社
製)]にて、35℃で一夜培養した試験菌株の菌液を同
培地で希釈し、1ml当りの菌数が約106になるよう
に調製した。使用した試験菌株は以下のとおりである。Next, each of the above suspensions was added to a medium for sensitivity measurement (Mueller-Hinton agar medium (manufactured by DIFCO)) which became 50 to 60 ° C. after thawing to 1 / of the medium.
After adding 9 volumes and thoroughly mixing, the mixture was divided into a petri dish and solidified to obtain an agar plate medium. In addition, an agar plate medium was prepared in the same manner as above using the same silica gel used in the examples as a sample, and this was used as a comparative example.・ Preparation of bacterial solution for inoculation Enrichment medium [Mueller Hinton Broth (Muel
Ler-Hinton Broth (manufactured by DIFCO)], the bacterial solution of the test strain that had been cultured overnight at 35 ° C. was diluted with the same medium so that the number of bacteria per ml was about 10 6 . The test strains used are as follows.
【0020】黄色ブドウ球菌:スタフィロコッカス オ
ーレオス(Staphylococcus aureu
s) IFO 12732 大腸菌:エスケリチャ コーライ(Escherich
ia coli) IFO 3301 緑膿菌:シュードモナス エルギノーサ(Pseudo
monas aeruginosa) IID P−1 サイトロバクター:サイトロバクター フレウンディ
(Citrobacter freundii) IF
O 12681 クレブシュラ:クレブシュラ ニューモニエ(Kleb
siella pneumoniae) IFO 13
277 プロテウス:プロテウス ブルガリス(Proteus
vulgalis)IFO 3988 サルモネラ:サルモネラ ガリナラム(Salmone
lla gallinarum) IFO 3163 セラチア:セラチア マルセセンス(Serratia
marcescens) IFO 12648 尚、黄色ブドウ球菌はグラム陽性菌に属するのに対し、
大腸菌、サイトロバクター、クレブシュラ、プロテウ
ス、サルモネラ及びセラチアはグラム陰性菌に属する。 ・培養 接種用菌液を寒天平板培地に、ニクロム線ループ(内径
約1mm)で2cm程度画線塗抹し、35℃で1日間培
養した。Staphylococcus aureus: Staphylococcus aureu
s) IFO 12732 E. coli: Escherichia coli
ia coli) IFO 3301 Pseudomonas aeruginosa: Pseudomonas aeruginosa (Pseudo)
monas aeruginosa) IID P-1 CYTOLOBACTOR: CYTOBACTER FREUNDII IF
O 12681 Klebshulla: Klebshulla New Monnier (Kleb
siella pneumoniae) IFO 13
277 Proteus: Proteus Bulgaris
vulgalis) IFO 3988 Salmonella: Salmonella Galinarum (Salmone)
lla gallinarum) IFO 3163 Serratia: Serratia marcescens (Serratia)
marcescens) IFO 12648 While Staphylococcus aureus belongs to Gram-positive bacteria,
Escherichia coli, Cytobacter, Klebsiella, Proteus, Salmonella and Serratia belong to Gram-negative bacteria. -Culturing The bacterial solution for inoculation was smeared on an agar plate medium with a nichrome wire loop (internal diameter of about 1 mm) for about 2 cm, and cultured at 35 ° C for 1 day.
【0021】[0021]
【表1】 [Table 1]
【0022】表1から明らかなように、実施例1〜5の
抗菌材を試料として混合した寒天平板培地ではグラム陰
性菌が選択的に発育を阻止された。このことから本発明
の抗菌材はグラム陰性菌に対する選択性を有する。一
方、比較例1は抗菌活性を有するものの、グラム陰性菌
に対する選択性はみられなかった。As is clear from Table 1, the growth of gram-negative bacteria was selectively inhibited on the agar plate medium containing the antibacterial materials of Examples 1 to 5 as a sample. Therefore, the antibacterial material of the present invention has selectivity for Gram-negative bacteria. On the other hand, Comparative Example 1 has antibacterial activity, but no selectivity for Gram-negative bacteria was observed.
【0023】[0023]
【発明の効果】以上述べたように、本発明のグラム陰性
菌に選択性を有する抗菌材はグラム陰性菌に対して選択
的に有効で、これを使用すればグラム陰性菌を選択的に
除菌することができる。INDUSTRIAL APPLICABILITY As described above, the antibacterial material of the present invention having selectivity for Gram-negative bacteria is selectively effective against Gram-negative bacteria, and when it is used, it selectively removes Gram-negative bacteria. Can be fungi.
Claims (3)
に担持させたことを特徴とするグラム陰性菌に選択性を
有する抗菌材。1. An antibacterial material having selectivity for Gram-negative bacteria, which comprises supporting a silver complex salt prepared from silver chloride on silica gel.
あることを特徴とする請求項1記載のグラム陰性菌に選
択性を有する抗菌材。2. The antibacterial material having selectivity for Gram-negative bacteria according to claim 1, wherein the silver complex salt is a thiosulfato silver complex salt.
陰性菌を選択的に除菌することを特徴とする選択的除菌
方法。3. A selective sterilization method comprising using the antibacterial material according to claim 1 to selectively eradicate Gram-negative bacteria.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20325693A JPH06122606A (en) | 1992-08-24 | 1993-08-17 | Antibacterial material selective to gram-negative bacteria and selective sterilization |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4-224421 | 1992-08-24 | ||
JP22442192 | 1992-08-24 | ||
JP20325693A JPH06122606A (en) | 1992-08-24 | 1993-08-17 | Antibacterial material selective to gram-negative bacteria and selective sterilization |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH06122606A true JPH06122606A (en) | 1994-05-06 |
Family
ID=26513825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP20325693A Pending JPH06122606A (en) | 1992-08-24 | 1993-08-17 | Antibacterial material selective to gram-negative bacteria and selective sterilization |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH06122606A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7661430B2 (en) | 2006-05-19 | 2010-02-16 | Richard Mason | Antimicrobial dental appliances including mouthguards and mouthpieces |
JP2015507609A (en) * | 2011-12-01 | 2015-03-12 | ローム アンド ハース カンパニーRohm And Haas Company | Antimicrobial composition of orthophenylphenol and silver |
-
1993
- 1993-08-17 JP JP20325693A patent/JPH06122606A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7661430B2 (en) | 2006-05-19 | 2010-02-16 | Richard Mason | Antimicrobial dental appliances including mouthguards and mouthpieces |
JP2015507609A (en) * | 2011-12-01 | 2015-03-12 | ローム アンド ハース カンパニーRohm And Haas Company | Antimicrobial composition of orthophenylphenol and silver |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bryaskova et al. | Synthesis, characterisation and antibacterial activity of PVA/TEOS/Ag-Np hybrid thin films | |
JP4143219B2 (en) | Simple medium and method for producing the same | |
Belaabed et al. | Synthesis of LTA zeolite for bacterial adhesion | |
JP6993846B2 (en) | Antibacterial agent | |
US20180049431A1 (en) | Antibacterial composite and method for preparing the same | |
JP2001070741A (en) | Humidifier | |
JPH06122606A (en) | Antibacterial material selective to gram-negative bacteria and selective sterilization | |
Samavati et al. | Antibacterial adsorptive membrane decorated via silver nanolayer for ammonia removal | |
CN105885063B (en) | A kind of preparation method of the medical temperature-sensitive hydrogel containing nano silver | |
JPS627747A (en) | Hydrophobic antifungal zeolite composition coated with silicone film and its production | |
CN116195581A (en) | Preparation method of a composite antibacterial material and application of the material | |
CN111374151A (en) | A kind of preparation method of multifunctional material containing TAA for sterilization, anti-protein adsorption and specific recognition | |
KR102034065B1 (en) | Mesoporous Carbon-Silver Composite With Antibacterial Activity And Menufacturing Method Thereof | |
JPH04243908A (en) | Antimicrobial phosphate intercalation compound and its production | |
CN112042673B (en) | A kind of silver fulvic acid antibacterial agent, its preparation method, its application and nylon material | |
CN116036344B (en) | Anti-infection dressing and preparation method thereof | |
JPH06125970A (en) | Antibacterial material having selectivity to gram-positive bacteria and selective elimination method thereof | |
AU613387B2 (en) | An inorganic carrier element comprising an amine-containing surface layer for the immobilization of microorganisms or cells, a process for the preparation thereof | |
CN115679685B (en) | Preparation method of copper ion antibacterial material | |
CN117682841B (en) | Antibacterial ceramic powder, preparation method thereof, antibacterial ceramic coating and application | |
JPH0680526A (en) | Antibacterial material | |
JPH061706A (en) | Method for producing antibacterial agent | |
JP3154365B2 (en) | Antibacterial resin molding | |
JPH03198857A (en) | Antibacterial deodorizing composition | |
CN119586608A (en) | Preparation of AgNPS-(SBA-15) molecular sieve antibacterial material and anti-deterioration treatment method for tobacco flavoring |